Central Council for Research in Ayurvedic Sciences (CCRAS) in collaboration with Directorate General of Health Services, Ministry of Health & Family Welfare has implemented and executed a programme viz. Integration of AYUSH (Ayurveda) component with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular diseases & Stroke (NPCDCS) programme in the identified districts of 3 states viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and Gaya (Bihar) to cater health care services and reduce the burden of NCDs by combining the strength of Ayurveda and Yoga. The programme was launched during Jan/Feb 2016 in 2 districts viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and in Gaya (Bihar) the programme was launched in April 2016.
The programme is successfully functional in 52 centers (49 CHCs and 3 District Hospitals) all 3 identified districts. Till December 2017, 241886 patients have been screened for selected Non Communicable Disease, out of which 54991 patients have been enrolled for selected NCDs under this programme and out of which 23699 Diabetic patients have been enrolled and given treatment, Dietary regimen and Yoga classes.
CCRAS has developed an anti-diabetic formulation namely AYUSH-82 and commercialized to several pharmaceutical companies through National Research Development Corporation (NRDC), New Delhi. CSIR, has developed after standardization and pre-clinical studies conducted jointly by CSIR-CIMAP and CSIR-NBRI a formulation BGR34, which is meant to be used by patients of newly diagnosed diabetes only as a measure of management of the disease. This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha.
The Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous body under the Ministry of AYUSH is actively involved in scientific process of drug development adopting prevalent guidelines such as Good Clinical Practices Guidelines for ASU drugs (GCP-ASU), Ministry of AYUSH and National ethical guidelines for Bio-Medical Research (ICMR), WHO guidelines for traditional medicines etc. as per requirement and as feasible through its peripheral institutes. Council through its drug development program is undertaking development of new formulations/drugs taking leads from Ayurvedic literature through a systematic process of drug development. viz standardization, preclinical safety & clinical study as per requirement.
CCRAS has developed and commercialized the following two drugs:
AYUSH 82 An Anti Diabetic Ayurvedic Formulation
AYUSH SG An Anti-Rheumatoid Arthritis preparation.
CCRAS has also undertaken the development of the following coded formulations which are at different phases of drug development:-
AYUSH Manas for Mental retardation/cognitive deficit
AYUSH QOL 2C for improving Quality of Life of Cancer patients
AYUSH Rasayan A & B in geriatric health
AYUSH C1 Oil for wound healing
AYUSH PJ-7 for Dengue fever
AYUSH M-3 for Migraine
AYUSH SL for Filariasis
AYUSH A for Bronchial Asthma
AYUSH D for Type II Diabetes Mellitus
Carctol S for Cancer
AYUSH K1 for Chronic Kidney Diseases